Joseph T. Morrissey Jr. - Mar 31, 2022 Form 4 Insider Report for Organon & Co. (OGN)

Role: Head of Manufacturing
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Joseph T. Morrissey, Jr.
Stock symbol: OGN
Transactions as of: Mar 31, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/4/2022, 06:07 PM
Previous filing: Mar 2, 2022
Next filing: May 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Award	$0	+11.8K		$0.00	11.8K	Mar 31, 2022	Common Stock	11.8K		Direct	F1, F2
transaction	OGN	Stock Option (right to buy)	Award	$0	+36.4K		$0.00	36.4K	Mar 31, 2022	Common Stock	36.4K	$34.93	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
F2	These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025.
F3	The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025.